Total Payments
$1,235
2024 Payments
$179.92
Companies
17
Transactions
66
Medicare Patients
1,192
Medicare Billing
$199,036
Payment Breakdown by Category
Food & Beverage$1,207 (97.7%)
Education$27.80 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,207 | 64 | 97.7% |
| Education | $27.80 | 2 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mylan Specialty L.P. | $154.53 | 8 | $0 (2023) |
| GlaxoSmithKline, LLC. | $148.61 | 7 | $0 (2024) |
| Allergan Inc. | $145.51 | 10 | $0 (2019) |
| Insmed, Inc. | $123.91 | 6 | $0 (2024) |
| GENZYME CORPORATION | $108.13 | 4 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $91.02 | 4 | $0 (2024) |
| Electromed, Inc. | $77.77 | 5 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $74.65 | 4 | $0 (2022) |
| Gilead Sciences, Inc. | $60.32 | 4 | $0 (2021) |
| Shionogi Inc | $44.86 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $179.92 | 8 | GENZYME CORPORATION ($108.13) |
| 2023 | $117.78 | 5 | Insmed, Inc. ($29.17) |
| 2022 | $374.26 | 17 | Mylan Specialty L.P. ($98.90) |
| 2021 | $131.98 | 7 | Mylan Specialty L.P. ($33.37) |
| 2020 | $81.36 | 4 | Shionogi Inc ($44.86) |
| 2019 | $73.58 | 6 | Allergan Inc. ($26.43) |
| 2018 | $154.60 | 11 | Allergan Inc. ($53.47) |
| 2017 | $121.76 | 8 | Allergan Inc. ($65.61) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.71 | General |
| Category: Immunology | ||||||
| 08/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.81 | General |
| Category: Immunology | ||||||
| 07/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Immunology | ||||||
| 07/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Immunology | ||||||
| 05/22/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: IMMUNOLOGY | ||||||
| 05/01/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Respiratory | ||||||
| 02/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $23.81 | General |
| 09/13/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: RESPIRATORY | ||||||
| 07/11/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $29.17 | General |
| Category: Respiratory | ||||||
| 05/09/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 02/22/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: IMMUNOLOGY | ||||||
| 12/15/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Respiratory | ||||||
| 12/14/2022 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 12/13/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $28.45 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: RESPIRATORY | ||||||
| 08/02/2022 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $30.90 | General |
| Category: HFCWO | ||||||
| 07/13/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/21/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 05/24/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $34.41 | General |
| Category: IMMUNOLOGY | ||||||
| 04/12/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Respiratory | ||||||
| 03/30/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/21/2022 | Vapotherm Inc | — | Food and Beverage | In-kind items and services | $27.60 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 150 | 326 | $37,654 | $13,828 |
| 2022 | 10 | 220 | 459 | $46,320 | $16,813 |
| 2021 | 13 | 377 | 904 | $199,281 | $72,128 |
| 2020 | 14 | 445 | 1,142 | $278,788 | $96,267 |
Total Patients
1,192
Total Services
2,831
Medicare Billing
$199,036
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 62 | 129 | $26,187 | $11,094 | 42.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,650 | $1,779 | 38.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 35 | $1,750 | $348.48 | 19.9% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 12 | 59 | $1,003 | $290.24 | 28.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 12 | 12 | $1,392 | $109.20 | 7.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 12 | 12 | $1,092 | $101.31 | 9.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 12 | 12 | $1,476 | $86.90 | 5.9% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 11 | 52 | $104.00 | $19.00 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 65 | 142 | $28,826 | $12,123 | 42.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $6,510 | $2,699 | 41.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 22 | 53 | $2,650 | $511.07 | 19.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 15 | 15 | $675.00 | $410.36 | 60.8% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 16 | 72 | $1,224 | $352.17 | 28.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 15 | 15 | $645.00 | $315.79 | 49.0% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2022 | 16 | 17 | $1,547 | $141.68 | 9.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 16 | 17 | $2,091 | $121.62 | 5.8% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 16 | 17 | $1,972 | $105.63 | 5.4% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 18 | 90 | $180.00 | $32.35 | 18.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 42 | 162 | $86,022 | $28,687 | 33.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 58 | 254 | $50,800 | $20,814 | 41.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 132 | $26,796 | $11,932 | 44.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 23 | 83 | $11,398 | $4,575 | 40.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 25 | 26 | $10,114 | $4,137 | 40.9% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 19 | 19 | $817.00 | $390.07 | 47.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 19 | 20 | $900.00 | $316.41 | 35.2% |
About Dr. Indira Sastry, M.D
Dr. Indira Sastry, M.D is a Pulmonary Disease healthcare provider based in Shreveport, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1659367175.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Indira Sastry, M.D has received a total of $1,235 in payments from pharmaceutical and medical device companies, with $179.92 received in 2024. These payments were reported across 66 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,207).
As a Medicare-enrolled provider, Sastry has provided services to 1,192 Medicare beneficiaries, totaling 2,831 services with total Medicare billing of $199,036. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Shreveport, LA
- Active Since 09/20/2005
- Last Updated 09/30/2015
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1659367175
Products in Payments
- AVYCAZ (Drug) $145.51
- TRELEGY ELLIPTA (Drug) $136.11
- Yupelri (Drug) $132.27
- Arikayce (Drug) $123.91
- DUPIXENT (Biological) $108.13
- ACTHAR (Biological) $91.02
- SMARTVEST (Device) $77.77
- OFEV (Drug) $59.33
- Fetroja (Drug) $44.86
- The Vest System Model 105 Home Care (Device) $37.63
- BREZTRI (Drug) $30.67
- inCourage (Device) $23.74
- YUPELRI (Drug) $22.26
- Wellcentive Undiv (Device) $18.34
- Veklury (Drug) $16.78
- NUZYRA (Drug) $16.62
- STIOLTO (Drug) $15.32
- FASENRA (Biological) $11.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Shreveport
Dr. Kirit Patel, M.d, M.D
Pulmonary Disease — Payments: $113,159
Pulmonary Disease $113,159
Ammar Alqaid, Md, MD
Pulmonary Disease — Payments: $16,562
Pulmonary Disease $16,562
Ashley Ferraro, Do, DO
Pulmonary Disease — Payments: $3,130
Pulmonary Disease $3,130
Sukhmani Boparai, Md, MD
Pulmonary Disease — Payments: $2,297
Pulmonary Disease $2,297
Kimberly Jones, M.d, M.D
Pulmonary Disease — Payments: $1,715
Pulmonary Disease $1,715
Randy Bryn, Md, MD
Pulmonary Disease — Payments: $572.77
Pulmonary Disease $572.77